Home AccuPulse Medical and Time Medical Announce Strategic Partnership to Drive Commercial Platform Innovation and Supply Chain Optimization

AccuPulse Medical and Time Medical Announce Strategic Partnership to Drive Commercial Platform Innovation and Supply Chain Optimization

Jun 02, 2025 10:59 CST Updated 10:59
AccuPulse

Developer of products in the field of cardiac electrophysiology

Image
Image
Image

On May 28, for the optimization of the supply chain and the rapid establishment of a national logistics distribution network in China,AccuPulse Medical Device (Shaoxing) Co., Ltd. ("AccuPulse Medical" for short) and Shanghai Taimei Medical Device Co., Ltd. ("Taimei Medical" for short) officially signed a strategic cooperation agreement in Shanghai to carry out collaboration on a commercial platform.AccuPulse CEO Yin Jie and Shanghai Taimei Medical Device Co., Ltd. General Manager Zhang Dongdi attended the signing ceremony, announcing that they will jointly create a more efficient and optimized medical supply chain ecosystem through logistics model optimization and business model innovation, promoting high-quality development in the electrophysiology medical industry.

Image

AccuPulse CEO Yin Jie (left) and Shanghai Taimei Medical Device Co., Ltd. General Manager Zhang Dongdi (right) represent the signing of the cooperation agreement.

Quickly Capture the Market

Build a Rapid Supply Chain and Logistics Distribution Network

This collaboration aims to promote the optimization of AccuPulse's supply chain by leveraging Taimei’s nationwide logistics and distribution network in China, improving the efficiency of product delivery to hospitals and the speed of logistics response to ensure timely fulfillment of clinical needs. A new consignment model will be implemented, utilizing equipment rental and deployment activities to increase AccuPulse's market share. The partnership will also explore the deep integration of electrophysiology consumables with AI technology to develop smarter and more precise surgical solutions. Additionally, a surgery outcomes database will be co-developed, using real-world data to inform product iteration and precision marketing, achieving a dual-driven approach between technology and market.

Image

Before the signing ceremony,AccuPulse's Sales Director Wang Daocheng introduced AccuPulse's sales strategy for the next three years.He pointed out: The emergence of new technologies will lead to a significant shift in the cardiac electrophysiology market landscape. AccuPulse's products have gained recognition from many clinical experts and peers. The sales team will also draw on the experience of foreign enterprises while integrating the characteristics of science and technology innovation companies to build a highly professional, strongly execution-driven, flexible, and efficient team, contributing AccuPulse’s efforts to promoting the localization of cardiac electrophysiology products in China.

Image

AccuPulse Marketing Director Kevin XuFirst of all, congratulations to both parties on the signing. The overall trend of PFA replacing RF treatment at home and abroad was shared with the attendees. Pulse technology is being increasingly accepted and advocated by clinical scholars due to its unique tissue selectivity. AccuPulse's self-developed cardiac pulse ablation system synchronizes with international innovative technologies. It has been certified by 17 clinical experts from eight top electrophysiology centers in China. The one-year follow-up effective rate of clinical research reached 87.7%. At the same time, most patients underwent surgery under local anesthesia. The 7.5F adjustable small loop is more suitable for Asian patients."New" Technology Empowers, "Heart" Awaits.AccuPulse will serve Chinese patients more broadly, committing to technological innovation and industrial upgrading, continuously enhancing independent innovation capabilities, increasing R&D investment, further extending the industry chain, and expanding into overseas markets.

Image

AccuPulse Channel Director Wang WeiIntroduced the channel goal of "One Body, Two Wings, and In-Depth Development" for AccuPulse Medical, marking the strategic cooperation between AccuPulse Medical and Shanghai Taimei Medical Device Co., Ltd.ProvideA solid theoretical foundation; nextWang Yong, Vice General Manager of Taimei MedicalHe introduced in detail the achievements Taimei Medical has made over the years and its future goals. He pointed out: The cooperation between Taimei Medical and AccuPulse represents an innovative exploration of both parties' business models. The electrophysiology field is a new track for Taimei Medical’s transformation towards high-quality development, and it is expected to make a positive contribution to the development of the electrophysiology industry.Zhou Xiaohong, CFO of Taimei Medical, and Xie Yali, Senior Manager of the Information Department, stated:Shanghai Taimei Medical Device Co., Ltd. has been deeply engaged in the medical device industry for many years with a platform-based model. Its collaboration with AccuPulse in the electrophysiology field, based on the principles of "joint promotion, joint connection, and shared benefits," will create greater value for the industry.

Image

AccuPulse CEO Yin Jie's Speech:"The platform-based model not only rapidly establishes logistics and distribution networks, reducing intermediate costs, but also enhances the precision of supply-demand matching through data sharing. This is an important step towards the intelligent transformation of the medical supply chain. We hope that through in-depth cooperation with Shanghai Taimei Medical Device Co., Ltd., we can improve the efficiency of medical device companies with better business models and services."

Image

Zhang Dongdi, General Manager of Taimei Medical, emphasized:"AccuPulse Medical Technology Co., Ltd. has always been committed to the electrophysiology field, focusing on providing patients with a one-stop solution for atrial fibrillation treatment. Shanghai Taimei Medical Device Co., Ltd., as a long-established company specializing in medical device logistics, distribution, and supply chain services, has accumulated decades of experience in orthopedics, rehabilitation, dentistry, and logistics distribution, becoming a trusted benchmark enterprise within the industry. This collaboration with AccuPulse represents an expansion of Taimei's service scope into the cardiovascular electrophysiology sector, which will play a significant role in various aspects such as new commercial consignment models, intelligent supply chains, deployment of electrophysiological equipment, and networked distribution and delivery systems."

Looking Forward

Image
Image

This collaboration is not only the integration of resources between two enterprises but also regarded as a landmark in the digital and intelligent transformation of AccuPulse Medical Technology Co., Ltd. and Shanghai Taimei Medical Device Co., Ltd.'s supply chains.Through collaborative innovation in a platform-based model, AccuPulse Medical and Shanghai Taimei Medical Device Co., Ltd. are expected to provide replicable experiences for the industry, promoting the overall efficiency of the medical industry chain.

AccuPulseDepartmentAccuPulse Medical Technology Co.Ltd. is on a mission to "make atrial fibrillation surgery simple, effective, and safer," continuously driving technological innovation.ServiceFor more AF patients, we never stop pursuing the ideal!